The US Food and Drug Administration (FDA ... U.S. are eligible to receive this season's Covid-19 vaccine, even if they have never been vaccinated against Covid-19 before,” Albert Bourla, Pfizer ...
Ken Paxton's lawsuit argues that the Pfizer COVID vaccine was less than 1 percent effective at fighting the disease.
The virus sends up to 160,000 people over 65 to hospitals every year. But just 15 percent have gotten the newly available ...
United States health authorities Monday gave full approval to the COVID-19 vaccine developed by Pfizer ... Moderna's drug is expected to be approved shortly. The Food and Drug Administration's ...
The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them ...
Two top federal health officials reportedly warned the Biden administration Thursday they might not rubber-stamp COVID vaccine ... FDA’s outside advisory committee is due to publicly review ...
Mizuho Securities initiated coverage on Vaxcyte Inc (NASDAQ: PCVX), a vaccine company targeting bacterial infectious diseases (primarily for disease prevention).
the Pfizer vaccine was approved for emergency use. The decision to give it full approval is likely to prompt more community college districts in California to require students or staff to be ...
Pfizer and BioNTech requested that the Food and Drug Administration expand vaccine authorization for children ages 12 ... “These submissions represent a critical step in Pfizer’s and BioNTech’s ...
News, May 07, 2010 FDA Approves Orphan Drug Status for Pancreatic Cancer Vaccine The FDA has approved ... for the treatment of pediatric Crohn's disease. News, January 18, 2008 New FDA Orphan ...
Available now, LIKMEZ™ is the first and only FDA-approved ready-to-use oral liquid metronidazole in the U.S. market. LIKMEZ™ is a novel presentation of a mainstay antibiotic drug, reinvented ...
